文献速递艾滋病与性传播感染

儿童早期HIV感染中免疫控制病毒血症与多次治疗中断后HIV特异性CD8+T细胞活性诱导相关

Immune control of HIV viraemia in early paediatric infection is associated with induction of HIV-specific CD8+ T-cell activity following multiple treatment interruptions.
PubMed 文献 · J Infect Dis · 2026-08-29

该研究基于南非早期ART治疗的儿童随机队列,比较Arm-1(初始ART后三次短程pVL指导的治疗中断)与Arm-2(持续ART),两组均在第二年进行延长ATI。结果显示Arm-1在延长ATI期间峰值和调定点pVL更低,并早期诱导HIV特异性CD8+T细胞应答;一名Arm-1参与者实现1.5个月pVL检测不到后因优势Gag CD8+表位病毒逃逸而失去免疫控制。

要点

  • 多次短程ATI诱导/增强HIV特异性CD8+T细胞应答
  • Arm-1在延长ATI期间峰值和调定点pVL低于Arm-2
  • 病毒逃逸可导致已获得的免疫控制丧失

核心结论

  • 多次ATI的短期病毒暴露与早期ART治疗儿童HIV特异性CD8+T细胞应答的诱导和/或增强及增强的HIV免疫控制相关。

研究设计与样本

  • 历史随机队列研究,纳入南非早期ART治疗的HIV感染婴儿,随机分为Arm-1(初始ART后三次短程pVL指导的治疗中断)和Arm-2(持续ART),两组均在第二年进行延长ATI,纵向评估病毒学结局、病毒测序和HIV特异性T细胞应答。

主要发现

  • 延长ATI期间,Arm-1参与者峰值和调定点pVL低于Arm-2,并早期诱导HIV特异性CD8+T细胞应答。
  • 一名Arm-1参与者在延长ATI期间实现1.5个月pVL检测不到,随后因优势Gag CD8+表位内病毒逃逸而失去免疫控制。

临床怎么用

  • 在早期ART治疗的儿童中,短程pVL指导的治疗中断策略可诱导HIV特异性CD8+T细胞应答并增强免疫控制,但需监测病毒逃逸。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Virus-specific CD8+ T-cells play an important part in HIV cure/remission in adults, yet their role in paediatric immune control is limited by tolerogenic early-life immunity. Very-early ART initiation, while effective in restricting viral reservoir size, also prevents antigenic exposure and, thereby, the induction of HIV-specific CD8+ T-cell responses. Analytical treatment interruption (ATI) is an established tool in cure/remission studies for assessing time to viral rebound and viral setpoint off ART yet the impact of ATI on HIV-specific immune responses and plasma viral load (pVL) remains understudied in paediatric populations. METHODS: We evaluated a historical randomised cohort of early ART-treated children in South Africa. Infants with HIV were randomized to either Arm-1, receiving an initial course of ART followed by three short, pVL-guided treatment interruptions, or Arm-2, receiving continuous ART. Both arms then underwent an extended ATI in the second year of life. Virological outcomes, viral sequencing, and HIV-specific T-cell responses were assessed longitudinally. RESULTS: During the extended ATI, Arm-1 participants, following multiple treatment interruptions, demonstrated a lower peak and set-point pVL compared to Arm-2, alongside an early induction of HIV-specific CD8+ T-cell responses. One Arm-1 participant achieved undetectable pVL for 1.5 months during the extended ATI, before losing immune control associated with viral escape within dominant Gag CD8+ T-cell epitopes. CONCLUSIONS: Short-term viral exposure from serial ATIs is associated with the induction and/or boosting of HIV-specific CD8+ T-cell responses and enhanced immune control of HIV in early ART-treated children.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Edgar JE, Parker HR, Thobakgale C, et al. Immune control of HIV viraemia in early paediatric infection is associated with induction of HIV-specific CD8+ T-cell activity following multiple treatment interruptions. J Infect Dis. 2026. PMID: 42667209. doi:10.1093/infdis/jiag440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。